o None
Entity Type
0001498382
DelMar Pharmaceuticals, Inc.
Berry Only Inc.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Kintara Therapeutics, Inc.
Jurisdiction of Incorporation/Organization
NEVADA
 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
 Kintara Therapeutics, Inc.  
Street Address 1 Street Address 2
 12707 HIGH BLUFF DR., SUITE 200  
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
 SAN DIEGO  CALIFORNIA  92130  858-350-4364 



3. Related Persons
Last Name First Name Middle Name
Zarrabian Saiid
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Brown Dennis
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Praill Scott
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Liatos John
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last Name First Name Middle Name
Hoffman Robert
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Toth Robert
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Johnson Laura
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Murphy Keith
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last Name First Name Middle Name
Rychnovsky Steven
Street Address 1 Street Address 2
12707 High Bluff Drive, Suite 200
City State/Province/Country ZIP/Postal Code
San Diego CALIFORNIA 92130
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   x Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

        Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance o Other
  o Residential  
  o Other Real Estate  
o Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale  2020-08-19 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security x Other (describe)
  Series C Convertible Preferred Stock


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? x Yes o No
 
Clarification of Response (if Necessary)  
 Adgero Acquisition Corp., the Company's wholly-owned subsidiary merged with and into Adgero BioPharmaceuticals Holdings, Inc. ("Adgero"), with Adgero surviving the merger and becoming a wholly-owned direct subsidiary of the Company.

11. Minimum Investment
Minimum investment accepted from any outside investor $ 0 USD

12. Sales Compensation
Recipient Recipient CRD Number o None
 Aegis Capital Corp.  15007
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
     
Street Address 1 Street Address 2
 810 7TH AVENUE  18TH FLOOR
City State/Province/Country ZIP/Postal Code
 NEW YORK  NEW YORK  10019
State(s) of Solicitation x All States x Foreign/Non-US
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 30000000 USD o Indefinite
Total Amount Sold $ 21772000 USD  
Total Remaining to be Sold $ 8228000 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 161


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $ 3000000 USD x Estimate
Finders' Fees $ 0 USD x Estimate
 
Clarification of Response (if Necessary)
 Assumes maximum commissions earned and over-allotment option exercised. Excludes expenses and value of up to 3,000 warrants received as compensation.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $ 0 USD x
Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Kintara Therapeutics Charts.
Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Kintara Therapeutics Charts.